NSE: IKS | BSE: 544309

Mid-range Performer

Download real time

1728.90 -23.10 (-1.32%)

37.00% Gain from 52W Low

125.7K NSE+BSE Volume

NSE 17 Sep, 2026 3:31 PM (IST)

29,663.3

Market Cap

Market Runner Up

Beta 1Year

Very Low volatility

Inventurus Knowledge Solutions Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for IKS, BSE:544309 Inventurus Knowledge Solutions Ltd.

Search Inside the pdf :

Inventurus Knowledge Solutions Ltd.

07 Sep 2026

1728.90

-1.32%

Inventurus Knowledge Solutions

Buy: Inventurus Knowledge Solut...

ICICI Direct

~US$35bn is outsourced today. With the outsourced market growing at ~12% CAGR, healthcare providers are increasingly outsourcing non-core workflows amid physician shortages, rising regulatory complexity and mounting reimbursement pressure. At ~US$380mn FY26 revenue, IKS has only ~1% share of the outsourced market, leaving a long runway for share gains. Its 450+ large enterprise customers,...

Inventurus Knowledge Solutions Ltd. is trading above its 200 day SMA of 1648.2

Inventurus Knowledge Solutions Ltd.

07 Aug 2026

1728.90

-1.32%

IKS Result Update Q1FY27

Buy: Inventurus Knowledge Solut...

Aditya Birla Money Limited

IKS's Q1FY27 numbers missed consensus, with revenue up 4.2% QoQ/20.7% YoY and EBITDA margins down 200bps QoQ at 33% (including one-time acquisition costs of Rs 200Mn). However, underlying demand remained healthy, driven by strong client mining and expansion across key accounts and growing traction in large health systems. We believe the recent TruBridge acquisition significantly expands IKS' presence in the rural and community healthcare market and strengthens its platform play. While IKS revised TruBridge's revenue run-rate to USD 300mn (vs. USD 340mn earlier), EBITDA remains...

Inventurus Knowledge Solutions Ltd. is trading above its 200 day SMA of 1648.2

Inventurus Knowledge Solutions Ltd.

06 Aug 2026

1728.90

-1.32%

Revenue in line; miss on margin and PAT

Buy: Inventurus Knowledge Solut...

Target

Motilal Oswal

Inventurus Knowledge Solutions’ (IKS) 1QFY27 USD revenue was up 12% YoY at USD97m (est. USD97m). INR revenue rose 21% YoY to INR8.9b (est. INR8.1b), with EBITDA of INR2.9b (est. INR3.1b) and margin of 33.0%, up 24% YoY (est. 35%), led by strong traction in top accounts.

Inventurus Knowledge Solutions Ltd. is trading below its 30 day SMA of 1771.9

Inventurus Knowledge Solutions Ltd.

15 May 2026

1728.90

-1.32%

Inventurus Knowledge Solutions Q4FY26 Result Update

Buy: Inventurus Knowledge Solut...

Aditya Birla Money Limited

Healthy outlook; platform model a key moat IKS's positioning as a platform-based system of action with embedded AI capabilities continues to differentiate it from point solution peers. Management remains confident of outpacing industry growth (outsourcing provider TAM expected to grow at ~12% CAGR), on the back of a healthy deal pipeline, cross-sell opportunities, platform-led expansion and scaling of outcome-oriented deals. Post the TruBridge acquisition, management has outlined a medium-term target of growing its EBITDA by nearly ~3x to...

Inventurus Knowledge Solutions Ltd. is trading above its 200 day SMA of 1648.2

Inventurus Knowledge Solutions Ltd.

26 Apr 2026

1728.90

-1.32%

TruBridge acquisition strengthens US presence

Buy: Inventurus Knowledge Solut...

Target

Motilal Oswal

IKS announced the acquisition of TruBridge, a leading healthcare IT and RCM services provider in the US, with revenue of USD347m in CY25, almost equal to IKS’s revenue base.

Inventurus Knowledge Solutions Ltd.'s price crossed below 100Day SMA today

Inventurus Knowledge Solutions Ltd.

05 Feb 2026

1728.90

-1.32%

In-line performance; momentum likely to sustain

Buy: Inventurus Knowledge Solut...

Motilal Oswal

IKS’s 3QFY26 USD revenue rose 19% YoY to USD93m, led by strong performance from top clients and healthy contribution from new deals and partnerships.

Inventurus Knowledge has gained 30.24% in the last 6 Months

Inventurus Knowledge Solutions Ltd.

12 Nov 2025

1728.90

-1.32%

I-Sec conference takeaways: IKS Health – a unique full-stack health tech player

Buy: Inventurus Knowledge Solut...

Recommendation Target

ICICI Securities Limited

We met IKS’ management at I-Sec conference. IKS is focusing on continuing the traction on full-platform deals, increasing cross-selling with AQuity clients, using AI to gain operating margin leverage and increase non-linearity between revenue and headcount growth and working with hospitals.

Inventurus Knowledge has gained 30.24% in the last 6 Months

Inventurus Knowledge Solutions Ltd.

10 Mar 2025

1728.90

-1.32%

From good to great

Hold: Inventurus Knowledge Solut...

ICICI Securities Limited

IKS Health (IKS) is a Platform as a Service (PaaS) company that caters to US’ healthcare provider segment. It focusses on outsourcing the routine chores of physicians. IKS’ platform has 16 key features, spanning across chores in a physician’s value chain, bundled into admin offerings and clinical offerings.